Chargement en cours...
非小细胞肺癌免疫治疗进展
In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...
Enregistré dans:
| Publié dans: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
中国肺癌杂志编辑部
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000202/ https://ncbi.nlm.nih.gov/pubmed/24398312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|